1887

Journal of General Virology header logo

Volume 77, Issue 6

Persistent Epstein—Barr virus infection in the common marmoset () Free

Abstract

Epstein—Barr virus (EBV) infection of the common marmoset causes long-term infection, with production of antibodies to virus-induced antigens, without clinical illness. Attempts to show the presence of EBV DNA in saliva of infected animals by PCR were initially unsuccessful, although slot-blot hybridization analysis demonstrated that viral DNA was present. Further investigations showed that most samples of pilocarpine-induced saliva, and 33% of the samples of whole mouth fluids (WMF) tested, were inhibitory to PCR. Similar results were found using human WMF. A method of assessing samples of marmoset WMF for the presence of EBV, by PCR using an EBV HI W probe, and removing inhibition with Chelex 100, is described. A total of 202 samples from 21 EBV infected, and seven non-infected animals was tested. Five seropositive animals shed virus on every occasion, and 15 intermittently. Two marmosets, infected as neonates, showed progressively increasing humoral responses to viral antigens, and shed virus on every occasion tested over 3 years. When mated with uninfected animals, the latter seroconverted 4 and 6 weeks later, respectively, and later shed virus into their WMF. The naturally infected animals were paired with naïve marmosets, and were able to pass on infection. These results establish that long-term, permissive EBV infection occurs in the common marmoset, and demonstrate again the similarities in the response to EBV between marmoset and man.

  • Received:
  • Accepted:
  • Published Online:
© Journal of General Virology 1996
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-77-6-1173
1996-06-01
2024-04-27
Loading full text...

Full text loading...

/deliver/fulltext/jgv/77/6/JV0770061173.html?itemId=/content/journal/jgv/10.1099/0022-1317-77-6-1173&mimeType=html&fmt=ahah

References

  1. Arrand J. R. 1992; Prospects for a vaccine against Epstein-Barr virus. Cancer Journal 5:188–193
     [Google Scholar]
  2. Baer R., Bankier A. T., Biggin M. D., Deininger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C., Seguin C., Tuffnell P., Barrell B. 1984; DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207–211
     [Google Scholar]
  3. Crouse C. A., Ban J. D., D’Alessio J. K. 1993; Extraction of DNA from forensic-type sexual assault specimens using simple, rapid sonication procedures. BioTechniques 15:641–644
     [Google Scholar]
  4. de Franchis R., Cross N. C. P., Foulkes N. S., Cox T. M. 1988; A potent inhibitor of Taq polymerase copurifies with human genomic DNA. Nucleic Acids Research 16:10355
     [Google Scholar]
  5. Desgranges C., Lenoir G., de Thé G., Seigneurin J. M., Hilgers J., Dubouch P. 1976; In vitro transforming activity of EBV 1. Establishment and properties of two EBV strains (M81 and M72) produced by immortalized Callithrix jacchus lymphocytes. Biomedicine 25:349–352
     [Google Scholar]
  6. Desgranges C., Lavoue M. F., Patet J., de Thé G. 1979; In vitro transforming activity of Epstein-Barr virus (EBV). II. Differences between M81 and B95-8 EBV strains. Biomedicine 30:102–108
     [Google Scholar]
  7. de Thé G., Ho H. C., Kwan H. C., Desgranges C., Favre M. C. 1970; Nasopharyngeal carcinoma (NPC). 1. Type of cultures derived from tumour biopsies and non-tumerous tissues of Chinese patients with special reference to lymphoblastoid transformation. International Journal of Cancer 6:189–206
     [Google Scholar]
  8. de Thé G., Geser A., Day N. E., Turkei P. M., Williams E. H., Beri D. P., Smith P. G., Dean A. G., Bornkamm G. W., Feorino P., Henle W. 1978; Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt’s lymphoma from Ugandan Prospective Study. Nature 274:756–761
     [Google Scholar]
  9. de The G., Dubouch P., Fontaine C., Wedderburn N., Carter R. L., Edwards M. B., Cohen B. 1980; Natural antibodies to EBV-VCA antigens in common marmosets [Callithrix jacchus) and response after EBV inoculation. Intervirology 14:284–291
     [Google Scholar]
  10. Emini E. A., Luka J., Armstrong M. E., Banker F. S., Provost P. J., Pearson G. R. 1986; Establishment and characterization of a chronic infectious mononucleosis-like syndrome in common marmosets. Journal of Medical Virology 18:369–379
     [Google Scholar]
  11. Epstein M. A. 1976; Epstein-Barr virus-is it time to develop a vaccine program?. Journal of the National Cancer Institute 56:697–700
     [Google Scholar]
  12. Epstein M. A., Morgan A. J., Finerty S., Randle B. J., Kirkwood J. K. 1985; Protection of cotton top tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine. Nature 318:287–289
     [Google Scholar]
  13. Felton S. C., Hoffmann C. C., Kreier J. P., Glaser R. 1984; Hematologic and immunologic responses in common marmosets (Callithrix jacobus) infected with Plasmodium knowlesi and Epstein-Barr virus. Laboratory Animal Science 34:164–168
     [Google Scholar]
  14. Finerty S., Tarlton J., Mackett M., Conway M., Arrand J. R., Watkins P. E., Morgan A. J. 1992; Protective immunization against Epstein-Barr virus-induced disease in cotton top tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vector. Journal of General Virology 73:449–453
     [Google Scholar]
  15. Fried M. W., Shindo M., Fong T., Fox P. C., Hoofnagle J. H., Bisceglie M. D. 1992; Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C. Gastroenterology 102:1306–1308
     [Google Scholar]
  16. Greenspan J. S., Greenspan D., Lennette E. T., Abrams D. I., Cognant M. A., Peterson V., Freese U. K. 1985; Replication of Epstein-Barr virus within the epithelial cells of oral “hairy” leukoplakia, an AIDS-associated lesion. New England Journal of Medicine 313:1564–1571
     [Google Scholar]
  17. Greenspan D., Greenspan J. S., de Souza Y., Lery J. A., Ungar A. M. 1989; Oral hairy leukoplakia in an HIV negative renal transplant recipient. Journal of Oral Pathology and Medicine 18:32–34
     [Google Scholar]
  18. Hanto D. W., Frizzera G., Purtilo D. T., Sakamoto K., Sullivan J. L., Saemundsen A. K., Klein G., Simmons R. L., Najarian J. S. 1981; Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Research 41:4253–4261
     [Google Scholar]
  19. Henle G., Henle W. 1966; Immunofluorescence in cells derived from Burkitt’s lymphoma. Journal of Bacteriology 91:1248–1256
     [Google Scholar]
  20. Henle W., Henle G., Zajac B. A., Pearson G., Waubke R., Scriba M. 1970; Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science 169:188–190
     [Google Scholar]
  21. Henle W., Henle G., Klein G. 1971; Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells. International Journal of Cancer 8:272–282
     [Google Scholar]
  22. Herbst H., Niedobitek G., Kneba M., Hummel M., Finn T., Anagnostopoulos I., Bergholz M., Krieger G., Stein H. 1990; High incidence of Epstein-Barr virus genomes in Hodgkin’s disease. American Journal of Pathology 137:13–18
     [Google Scholar]
  23. Ho J. H. C. 1972; Current knowledge of the epidemiology of nasopharyngeal carcinoma - a review. In Oncogenesis and Herpesviruses pp. 357–366 Edited by Biggs P. M., de The G. Payne L. N. Lyon: IARC;
     [Google Scholar]
  24. Imai S., Koizumi S., Sugiura M., Tokunaga M., Uemura Y., Yamamoto N., Tanaka S., Sato E., Osato T. 1994; Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proceedings of the National Academy of Sciences, USA 91:9131–9135
     [Google Scholar]
  25. Israele V., Shirley P., Sixbey J. W. 1991; Excretion of the Epstein-Barr virus from the genital tract of men. Journal of Infectious Diseases 163:1341–1343
     [Google Scholar]
  26. Johnston D. A., Knight A. M., Naylor B. A., Wedderburn N., Mitchell G. H. 1990; Monoclonal antibodies from Epstein-Barr virus-transformed lymphocytes of common marmosets (Callithrix jacchus) immune to malaria. Journal of Immunological Methods 127:187–195
     [Google Scholar]
  27. Junker A. K., Thomas E. E., Radcliffe A., Forsyth R. B., Davidson A. G. F., Rymo L. 1991; Epstein-Barr virus shedding in breast milk. American Journal of Medical Sciences 302:220–223
     [Google Scholar]
  28. Khan G., Kangro H. O., Coates P. J., Heath R. B. 1991; Inhibitory effects of urine on the polymerase chain reaction for cytomegalovirus DNA. Journal of Clinical Pathology 44:360–365
     [Google Scholar]
  29. Labrecque L. G., Barnes D. M., Fentiman I. S., Griffin B. E. 1995; Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Research 55:39–45
     [Google Scholar]
  30. Landau Z., Gross R., Sanilevich A., Friedmann A., Mitrani-Rosenbaum S. 1994; Presence of infective Epstein-Barr virus in the urine of patients with infectious mononucleosis. Journal of Medical Virology 44:229–233
     [Google Scholar]
  31. Liou T., Chang T., Young K., Lin X., Lin C., Wu H. 1992; Detection of HCV RNA in saliva, urine, seminal fluid, and ascites. Journal of Medical Virology 37:197–202
     [Google Scholar]
  32. Morgan A. J., Allison S., Finerty S., Scullion F. T., Byars N. E., Epstein M. A. 1989; Validation of a first-generation Epstein-Barr virus preparation suitable for human use. Journal of Medical Virology 29:74–78
     [Google Scholar]
  33. Niedobitek G., Agathanggelou A., Finerty S., Tierney R., Watkins P., Jones E. L., Morgan A., Young L. S., Rooney N. 1994; Latent Epstein-Barr virus infection in cottontop tamarins. American Journal of Pathology 145:969–978
     [Google Scholar]
  34. Noordhoek G. T., Kolk A. H. J., Bjune G., Catty D., Dale J. W., Fine P. E. M., Godfrey-Faussett P., Cho S., Shinnick T., Svenson S. B., Wilson S., van Embden J. D. A. 1994; Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. Journal of Clinical Microbiology 32:277–284
     [Google Scholar]
  35. Ochert A. S., Boulter A. W., Birnbaum W., Johnson N. W., Teo C. G. 1994a; Inhibitory effect of salivary fluids on PCR: potency and removal. PCR Methods and Applications 3:365–368
     [Google Scholar]
  36. Ochert A., Slomka M. J., Ellis J., Teo C. G. 1994b; Use of Chelex® 100 in the extraction of viruses from diverse cell-free clinical samples for PCR. Edited by Rolfs A., Weber-Rolfs I., Finckh U. In Methods in DNA Amplification pp. 47–53 London: Plenum Press;
     [Google Scholar]
  37. Pedneault L., Katz B. Z. 1993; Comparisons of polymerase chain reaction and standard Southern blotting for the detection of Epstein-Barr virus DNA in various biopsy specimens. Journal of Medical Virology 39:33–43
     [Google Scholar]
  38. Puchhammer-Stockl E., Mor W., Kundi M., Heinz F. X., Hofmann H., Kunz C. 1994; Prevalence of hepatitis-C virus RNA in serum and throat washings of children with chronic hepatitis. Journal of Medical Virology 43:143–147
     [Google Scholar]
  39. Rickinson A. B., Rowe M., Hart I. J., Yao Q. Y., Henderson L. E., Rabin H., Epstein M. A. 1984; T-cell mediated regression of “spontaneous” and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with Cyclosporin A. Cellular Immunology 87:646–658
     [Google Scholar]
  40. Sixbey J. W., Lemon S. M., Pagano J. S. 1986; A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet ii:1122–1124
     [Google Scholar]
  41. Takamatsu K., Koyanagi Y., Okita K., Yamamoto N. 1990; Hepatitis C virus RNA in saliva. Lancet 336:1515
     [Google Scholar]
  42. Thomas J. A., Crawford D. H. 1989; Epstein-Barr virus-associated B-cell lymphomas in AIDS and after organ transplantation. Lancet i:1075–1076
     [Google Scholar]
  43. van Zwet A. A., Thus J. C., Kooistra-Smid A. M. D., Schirm J., Snijder J. A. M. 1994; Use of PCR with feces for detection of Helicobacter pylori infections in patients. Journal of Clinical Microbiology 32:1346–1348
     [Google Scholar]
  44. Walsh P. S., Metzger D. A., Higuchi R. 1991; Chelex® 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. BioTechniques 10:506–513
     [Google Scholar]
  45. Wedderburn N., Edwards J. M. B., Desgranges C., Fontaine C., Cohen B., de The G. 1984; Infectious mononucleosis-like response in common marmosets infected with Epstein-Barr virus. Journal of Infectious Diseases 150:878–882
     [Google Scholar]
  46. Yao Q. Y., Rickinson A. B., Epstein M. A. 1985; A reexamination of the Epstein-Barr virus carrier state in healthy seropositive individuals. International Journal of Cancer 35:35–42
     [Google Scholar]
  47. zur Hausen H., Schulte-Holthausen H., Klein G., Henle W., Henle G., Clifford P., Santesson L. 1970; EB-virus DNA in biopsies of Burkitt tumors and anaplastic carcinomas of the nasopharynx. Nature 228:1056–1058
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-77-6-1173
Loading
Persistent Epstein—Barr virus infection in the common marmoset (Callithrix jacchus)
J. Gen. Virol. 77, 1173 (1996); https://doi.org/10.1099/0022-1317-77-6-1173
/content/journal/jgv/10.1099/0022-1317-77-6-1173
/content/journal/jgv/10.1099/0022-1317-77-6-1173
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error